Temperature distribution in target tumor tissue and photothermal tissue destruction during laser immunotherapy

2016 ◽  
Author(s):  
Austin Doughty ◽  
Aamr Hasanjee ◽  
Alex Pettitt ◽  
Kegan Silk ◽  
Hong Liu ◽  
...  
Volume 4 ◽  
2004 ◽  
Author(s):  
Ashvinikumar V. Mudaliar ◽  
Elaine P. Scott

Radio-frequency (RF) ablation is one of the most widely used methods for the treatment of hepatic malignancies. A finite element method (FEM) analysis was employed to determine the thermal dose delivered to the tumor/tissue region. We simulated heating within a RF probe implanted in generic tumor surrounded by healthy tissue using ANSYS. The 3-D model consists of a tumor / tissue region into which the RF probe is embedded inside the tumor. One-quarter symmetry was then invoked. The blood flow was modeled using Penne’s bio-heat transfer equation with differing perfusion rates between the healthy tissue and tumor volume based on literature values. The resulting temperature distribution throughout the region was determined over time. A program was written in Visual Basic to extract the temperature distribution data in the tumor/tissue region and calculate the thermal dose throughout the region. This was done by using a time–temperature Arrhenius relationship for chemical and physical rate process. Tissue necrosis is assumed complete when a thermal dose of one hour has been achieved at 43 °C. In the present study, the geometry of the electrode had a significant effect on the size of the volume of necrosis. It was found that the lower portion of the tumor did not receive the specified thermal dose relative to the upper portion of the tumor in single setting during the RF ablation therapy. This might be due to the Ni-Ti electrode, which protruded only from the top surface of the trocar. The effectiveness of the existing probe can be improved by having one more set of electrodes protruding out from the lower curved surface of the trocar. It was found that the modified probe significantly improved heating in the lower portion of tumor/tissue area, providing more symmetry between the upper and lower portion.


2009 ◽  
Vol 3 (2) ◽  
Author(s):  
M. Shenoi ◽  
E. Cressman

To overcome the limitations of existing ablation techniques, we propose a novel combinatorial approach that would utilize the thermal and chemical destructive effects of exothermic chemical reactions, such as an acid/base neutralization reaction, to treat solid tumors. Thermochemical ablation is a potential technique for percutaneous probe-based tumor therapy. It involves simultaneous intratumoral delivery of multiple reagents resulting in thermal energy released by an exothermic reaction to ablate tumor tissue with concurrent generation of a hyperosmolar byproduct that could accentuate tumor destruction. Besides the benefit of synergistic thermal and chemical effects for tumor tissue destruction, this technique is potentially highly cost-effective, easy to implement, and able to treat larger sized tumors. Our hypothesis is that thermochemical ablation can create an evenly distributed zone of coagulation in tumor tissue without systemic toxicity. A prototype device assembled using off-the-shelf components is being investigated in our lab for concurrent intraparenchymal delivery of an acid and a base. The distal portion of the multi-lumen device allows for passive mixing of the reagents before entering the tissue. The prototype device also satisfies other desirable design criteria such as rigidity to penetrate body tissue, reduced diameter, chemical stability to reagents, etc. However, the device can be improved upon by incorporating additional characteristics such as optimized imaging characteristic for real-time visualization and localization within tumor tissue, MRI compatibility, thermal insulation, improved mixing at the tip, etc. Our lab is currently working on improving the design of the infusion device as well as assessing the feasibility of the thermochemical ablation technique in vitro and in vivo. While currently being targeted conservatively for palliative therapy of unresectable or late-stage aggressive malignancies such as hepatocellular carcinoma, thermochemical ablation has potential use in the therapy of a majority of solid tumors such as breast cancer, lung cancer, prostate cancer, renal cancer, sarcomas, etc.


2017 ◽  
Author(s):  
Shaojie Liu ◽  
Austin Doughty ◽  
Sana Mesiya ◽  
Alex Pettitt ◽  
Feifan Zhou ◽  
...  

2007 ◽  
Author(s):  
Surya C. Gnyawali ◽  
Yichao Chen ◽  
Feng Wu ◽  
Kenneth E. Bartels ◽  
Jerry W. Ritchey ◽  
...  

2006 ◽  
Author(s):  
Yichao Chen ◽  
Surya Gyanwalib ◽  
Jeremy Bjorlie ◽  
Kirill Andrienko ◽  
Hong Liu ◽  
...  

Author(s):  
D. C. Swartzendruber ◽  
Norma L. Idoyaga-Vargas

The radionuclide gallium-67 (67Ga) localizes preferentially but not specifically in many human and experimental soft-tissue tumors. Because of this localization, 67Ga is used in clinical trials to detect humar. cancers by external scintiscanning methods. However, the fact that 67Ga does not localize specifically in tumors requires for its eventual clinical usefulness a fuller understanding of the mechanisms that control its deposition in both malignant and normal cells. We have previously reported that 67Ga localizes in lysosomal-like bodies, notably, although not exclusively, in macrophages of the spocytaneous AKR thymoma. Further studies on the uptake of 67Ga by macrophages are needed to determine whether there are factors related to malignancy that might alter the localization of 67Ga in these cells and thus provide clues to discovering the mechanism of 67Ga localization in tumor tissue.


Sign in / Sign up

Export Citation Format

Share Document